Pediatrics

Residents are required to complete 12, one-month calendar rotations. 

•     Orientation 
•     General Pediatrics I 
•     PICU I 
•     NICU I 
•     Selective rotation in NICU or CICU (Resident must complete an additional rotation in one of these areas) 
•     Inpatient hematology/oncology 
•     CICU I 
•     Research 

Residents select 4 electives 

•     Clinical toxicology/poison control 
•     Infectious disease 
•     Nephrology 
•     Outpatient hematology/oncology 
•     Emergency medicine 
•     Other* 

*May also elect to repeat one to the required rotations as above. 

Unless other specified below, residents complete these longitudinal rotations from July through June each academic year.  

•     Research 
•     Staffing 
•     Teaching  
•     Ambulatory Care (1 half-day per week, August-June) 
•     Management 

In addition to this, residents are also expected to document coverage of the required pediatric disease states listed at the end of the ASHP Educational Outcomes, Goals, and Objectives for PGY2 Pediatric Pharmacy residents.  

The resident delivers at a minimum of two lectures to Pharm.D. students and other interprofessional learners throughout the year. Teaching also occurs throughout the year as the resident presents interdisciplinary in-­services to the medical and nursing staff and assists with precepting of Pharm.D. students in the experiential portion of their curriculum. The resident assumes primary precepting responsibility for P4 students during the latter part of the residency. 

Residents complete a research curriculum which includes the University of Oklahoma Health Campus Institutional Review Board (IRB) certification for conducting human research and specific research training sessions through Resident Rounds. Each resident designs and executes an original research project under the mentorship of their research committee, which consists of the residency program director, an expert in the practice area in which research will be conducted, and an expert in study design, data analysis, and statistical methods. Residents present preliminary research findings during a podium presentation at the Pediatric Pharmacy Association Annual Meeting and the Oklahoma Pharmacy Residency Conference. In accordance with ASHP standards, residents prepare a high-quality manuscript based on their research findings. 

The resident participates in the peer-review of at least two manuscripts submitted for publication. The resident is also expected to contribute to the literature through preparation and publication of a newsletter article, a case report or review article, and their original research. 

The resident develops practice management skills through participation in institutional projects and committee work at The Oklahoma Children’s Hospital at OU Health. In addition, the resident develops a leadership philosophy through readings and discussions with the leadership preceptor and one-on-one meetings with local pharmacy leaders. 

Professional Organization Involvement 
Resident involvement in local and national professional organizations (as their residency schedule allows) is encouraged. Examples include: 

• Oklahoma Society of Health-System Pharmacists (OSHP) 
• American Society of Health-System Pharmacists (ASHP) 
• American College of Clinical Pharmacy (ACCP) 
• American Association of Colleges of Pharmacy (AACP) 
• Pediatric Pharmacy Association (PPA) 

University of Oklahoma College of Pharmacy Committees
Resident involvement in college committees is also required. Examples include: 

• One academic committee to support the College 
• Other meetings based on resident interests 

PGY2 Pediatric residents will attend one national and one regional meeting during the year. Residents travel to the ASHP Midyear Clinical Meeting in December to present their research projects as a poster and participate in the Residency Showcase. In the spring, residents will present a platform presentation at the Oklahoma Residency Research Conference hosted by the Oklahoma Society for Health System Pharmacists. 

PGY2 Pediatric residents are expected to achieve 80% of these educational outcomes from the required ASHP PGY2 Pediatric Residency competency, areas, goals, and objectives (CAGOS). The remaining 20% must be assessed at a minimum of satisfactory progress. These include the objectives under the five required competency areas (R1-patient care, R2-advancing practice and improving patient care, R3-leadership and management, R4- teaching/education/dissemination of knowledge, RS-management of medical emergencies) as well as the objectives under two of the elective competency areas (E4-added skills for pediatric pharmacy scholarship). 

NMS Program Codes:  

• 564261 

Application Deadline: January 2, 2026 
Start Date: July 1, 2026 
Length of Program: 12-months 

Interested applicants must register with the National Matching Service. Applications will only be accepted through Pharmacy Online Residency Centralized Application Service (PhORCAS) by the application deadline.  

Required Application Materials 

• Letter of intent 
• Curriculum vitae 
• Completed PhORCAS application 
• Transcripts from Doctor of Pharmacy Coursework 
• Three standardized PhCORAS references 

Pharmacy Residency Reference Writing Tips 

• Ashley Benedict, Pharm.D., Pediatric Clinical Pharmacist, Oklahoma Children’s Hospital at OU Health. Practice area: General pediatrics. 
• Whitney Bueno, Pharm.D., Pediatric Clinical Pharmacist, Oklahoma Children's Hospital at OU Health. Practice area: Outpatient ambulatory care in hematology and oncology. 
• Jennifer Dannelley, Pharm.D., Pediatric Clinical Pharmacist, Oklahoma Children’s Hospital at OU Health. Practice area: Outpatient ambulatory care in cystic fibrosis, pulmonology. 
• Erica Fuchs, Pharm.D., BCPPS, Pediatric Clinical Pharmacist, Oklahoma Children’s Hospital at OU Health. Practice area: NICU 
• Elisabeth Kneeland, Pharm.D., Clinical Pharmacy Manager, Oklahoma Children’s hospital at OU Health. Practice area; Practice management. 
• Jennifer Le, Pharm.D., BCPPS, Pediatric Clinical Pharmacist, Oklahoma Children's Hospital at OU Health. Practice area: Inpatient hematology and oncology, stem cell transplant.  
• Teresa V. Lewis, Pharm.D., BCPS, Associate Professor, Department of Pharmacy: Clinical and Administrative Sciences. Practice area: Nephrology, renal transplant, and inpatient general pediatrics. 
• Jamie Miller, Pharm.D., BCPPS, FPPA, FASHP, Professor, Department of Pharmacy: Clinical and Administrative Sciences. Practice area: NICU.  
• Andrea Nguyen, Pharm.D., Pediatric Clinical Pharmacist, Oklahoma Children’s Hospital at OU Health. Practice area: Maternal Fetal Medicine and antimicrobial Stewardship 
• Eszter Moore, Pharm.D., CSPI, Certified specialist in Poison Information, Oklahoma Poison Center. Practice area: Toxicology.  
• Natalie Nix, Pharm.D., Pediatric Clinical Pharmacist, Oklahoma Children’s Hospital at OU Health. Practice area: PICU. 
• Misty Oldham, Pharm.D., BCPS, AAHIVP, Associate Professor, Department of Pharmacy: Clinical and Administrative Sciences. Practice area: Outpatient HIV and inpatient infectious disease. 
• Avery Parman, Pharm.D., Pediatric Clinical Pharmacist, Oklahoma Children's Hospital at OU Health. Practice area: Emergency medicine. 
• Katy Stephens, Pharm.D., BCPPS, Pediatric Clinical Pharmacist, Oklahoma Children’s Hospital at OU Health. Practice area: CICU and cardiac transplant.